| Date | Event | Impact |
|---|---|---|
| Oct 1 | Alabama indoor vaping ban (SB 9) effective | Vaping banned in all public indoor spaces |
| Oct 1 | Virginia tobacco retailer registration begins | New compliance burden for VA retailers |
| Oct 19 | Pennsylvania ENDS directory enforcement begins | Non-directory products subject to seizure |
| Oct 27 | Schumer's 30-day FDA deadline expires | FDA must produce formal report on illicit vape investigation |
| Nov (TBD) | Heidi Overton confirmation vote (expected) | New FDA commissioner shapes enforcement priorities |
What to watch: The FDA's response to Schumer by October 27 will be the single most important signal for the industry's direction. If the agency commits to specific enforcement targets (seizure quotas, retailer inspections, customs holds), the compliant oligopoly scenario accelerates. If the response is vague or defers to the new commissioner, the status quo persists — but the political pressure won't go away.
